Back to Journals » Drug Design, Development and Therapy » Volume 9

Review

Brentuximab vedotin for relapsed or refractory Hodgkin’s lymphoma

       
Total article views   HTML views PDF downloads Totals
13,117 Dovepress* 10,460+ 1,890 12,350
PubMed Central* 2,657 729 3,386
Totals 13,117 2,619 15,736
*Since 23 March 2015
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar